Dual cancer targeting using estrogen functionalized chitosan nanoparticles loaded with doxorubicin-estrone conjugate: A quality by design approach
- 1 December 2020
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 164, 2881-2894
Abstract
No abstract availableKeywords
Funding Information
- Anusandhan National Research Foundation
- Department of Science and Technology, Government of Kerala
- Department of Science and Technology, Ministry of Science and Technology, India (SB/YS/LS-333/2013)
This publication has 39 references indexed in Scilit:
- Estrogen-Anchored pH-Sensitive Liposomes as Nanomodule Designed for Site-Specific Delivery of Doxorubicin in Breast Cancer TherapyMolecular Pharmaceutics, 2011
- Lactoferrin-Conjugated Dendritic Nanoconstructs for Lung Targeting of MethotrexateJournal of Pharmaceutical Sciences, 2011
- Promising molecular targeted therapies in breast cancerIndian Journal of Pharmacology, 2011
- Preparation and characterisation of core–shell CNTs@MIPs nanocomposites and selective removal of estrone from water samplesTalanta, 2011
- Micro- and nanocarrier-mediated lung targetingExpert Opinion on Drug Delivery, 2010
- Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluationJournal of Drug Targeting, 2009
- Targeted delivery of doxorubicin via estrone-appended liposomesJournal of Drug Targeting, 2008
- Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cellsOncogene, 2001
- Iodination and Heck alkynylation of 5,15-diphenylporphyrin. A convenient entry to asymmetrically meso-substituted porphyrinsJournal of the Chemical Society, Chemical Communications, 1995
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI: Journal of the National Cancer Institute, 1991